SoA- Schedule of Activities
Showing 1 - 25 of >10,000
Invasive Breast Cancer, Post-mastectomy Trial in New York (Radiotherapy)
Recruiting
- Invasive Breast Cancer
- Post-mastectomy
- Radiotherapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 17, 2022
Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- standard combination chemotherapy
- decitabine
-
Edegem, Antwerpen, Belgium
- +52 more
Sep 13, 2022
Ewing Sarcoma Trial in Warsaw (Naxitamab)
Not yet recruiting
- Ewing Sarcoma
-
Warsaw, Mazowian, PolandMother and Child Institute
Jul 28, 2023
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Carboplatin)
Recruiting
- Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Pembrolizumab
- +3 more
-
Kuala Lumpur, MalaysiaUniversity Malaya Medical Centre
Nov 1, 2022
Prostate Cancer Trial in Tampa (Abiraterone Acetate)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 3, 2023
Development of Artefact Removal and Physical Activity Algorithm
Recruiting
- Exercise
- +2 more
- Wearing heart rate monitors
-
Edegem, Antwerp, BelgiumUniversity Hospital Antwerp
Jun 2, 2023
Lifestyle-related Condition Trial (Expert health counseling)
Not yet recruiting
- Lifestyle-related Condition
- Expert health counseling
- (no location specified)
Dec 27, 2022
COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)
Completed
- COVID-19
- COVID-19 Immunisation
- mRNA-1273
-
Decatur, Georgia
- +2 more
Jan 26, 2023
Decreasing Destructive Behavior, Increasing Functional Communicative Behavior Trial in New Brunswick, Somerset (Traditional
Not yet recruiting
- Decreasing Destructive Behavior
- Increasing Functional Communicative Behavior
- Traditional Schedule Thinning
- +2 more
-
New Brunswick, New Jersey
- +1 more
Mar 29, 2023
Neuroblastoma, High-risk Neuroblastoma, Metastatic Neuroblastoma Trial in United States (OPT-821 (QS-21), oral ß-glucan)
Recruiting
- Neuroblastoma
- +2 more
- OPT-821 (QS-21)
- oral β-glucan
-
Basking Ridge, New Jersey
- +6 more
Sep 21, 2023
COVID-19, Lymphocytopenia Trial in Brazil (Interleukin-7, PLACEBO)
Terminated
- COVID-19
- Lymphocytopenia
- Interleukin-7
- PLACEBO
-
Porto Alegre, RIO Grande DO SUL, Brazil
- +5 more
Mar 30, 2022
HRD 100 Gene Expression High, Triple Negative Breast Cancer Trial in Kuala Lumpur (Talazoparib)
Recruiting
- HRD 100 Gene Expression High
- Triple Negative Breast Cancer
-
Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, MalaysiaUniversity Malaya Medical Centre
Mar 15, 2022
Information Disclosure Trial in Yaoundé (Cartoon video describing study information notice)
Recruiting
- Information Disclosure
- Cartoon video describing study information notice
-
Yaoundé, Centre, CameroonHD SOA
Jul 26, 2022
Technology, Signs and Symptoms, Respiratory Trial in Hong Kong (Air quality sensors)
Not yet recruiting
- Technology
- Signs and Symptoms, Respiratory
- Air quality sensors
-
Hong Kong, Hong KongHaven of Hope Woo Ping Care & Attention Home
Apr 18, 2023
COVID-19, Lymphocytopenia Trial in United Kingdom (Interleukin-7, Placebos)
Terminated
- COVID-19
- Lymphocytopenia
- Interleukin-7
- Placebos
-
Birmingham, United Kingdom
- +12 more
Mar 30, 2022
Contrast Enhancement in Magnetic Resonance Imaging, CNS Pathology Trial in Worldwide (Gadoquatrane (BAY1747846), Gadobutrol,
Not yet recruiting
- Contrast Enhancement in Magnetic Resonance Imaging
- Central Nervous System Pathology
- Gadoquatrane (BAY1747846)
- +3 more
-
Indian Wells, California
- +90 more
Jun 25, 2023
Charcot-Marie-Tooth Disease Trial in Worldwide ((RS)-baclofen, naltrexone HCl and D-sorbitol, Placebo)
Active, not recruiting
- Charcot-Marie-Tooth Disease
- (RS)-baclofen, naltrexone hydrochloride and D-sorbitol
- Placebo
-
Los Angeles, California
- +49 more
May 3, 2022
COVID-19 Disease Trial in Tel-Aviv (Exosomes overexpressing CD24)
Active, not recruiting
- COVID-19 Disease
- Exosomes overexpressing CD24
-
Tel-Aviv, IsraelTel-Aviv Sourasky Medical Center
Jul 18, 2021
Chronic Stroke, Paralysis Trial in Butler (Active Biophoton Generators, Inactive Biophoton Generators)
Recruiting
- Chronic Stroke
- Paralysis
- Active Biophoton Generators
- Inactive Biophoton Generators
-
Butler, PennsylvaniaTesla MedBed Center at Butler-PA
Jun 8, 2023
Polio Trial (polio vaccines: nOPV2, bOPV, IPV)
Not yet recruiting
- Polio
- polio vaccines: nOPV2, bOPV, IPV
- (no location specified)
Nov 2, 2023
Contrast Enhancement in Magnetic Resonance Imaging, Non-central Nervous System Pathology Trial in Worldwide (Gadoquatrane
Not yet recruiting
- Contrast Enhancement in Magnetic Resonance Imaging
- Non-central Nervous System Pathology
- Gadoquatrane (BAY1747846)
- +3 more
-
Birmingham, Alabama
- +106 more
Jun 25, 2023